Home Guides

Guides

Why Is the US CBD Market So Attractive?

Overall, the US has one of the most attractive markets for cannabis companies. Compared to Canada, the US market is expected to have a...

Cannabis ETFs: Why Are They Less Risky?

For our analysis of cannabis ETFs, we've considered the ETFMG Alternative Harvest ETF, the Horizons ETFs, and the Cambria Cannabis ETF.

A Guide to Marijuana Laws in Massachusetts

420 Investor Daily offers investors a detailed overview of the status of medical and recreational cannabis legalization in Massachusetts.

Cannabis Market Segments & Strategies

The strategy roadmap How cannabis companies succeed in the recreational use market will depend on the strategy they pursue. There are primarily two broad strategies to...

Cannabis Laws in Florida: Everything Investors Need to Know

Curious about how cannabis legalization works in Florida? We round up everything you need to know about both medical marijuana and the recreational sector.

Investing in the Cannabis Industry

The cannabis industry has been around for a long time, but it used to focus on medical cannabis. However, the industry has undergone a...

Must Read

Canopy Growth under Investigation for Fraud

Law firm Ademi & O'Reilly is currently investigating fraud claims against the global cannabis producer Canopy Growth (CGC) (WEED).

Cannabis Sector: The Worst Isn’t Over

The cannabis sector is running high on negative sentiment after two of its biggest players reported disappointing earnings on November 14.

Charlotte’s Web to Develop Cannabis Spirits?

Charlotte's Web Holdings recently appointed Jacques Tortoroli to its board of directors. He previously served as Bacardi's chief administrative officer.

Canopy Growth’s Q2 Earnings: Top Five Takeaways

Leading cannabis producer Canopy Growth reported disappointing fiscal 2020 second-quarter earnings results on November 14.

Tilray Struggles Post-Q3 as Most Analysts Say ‘Hold’

Like many of its peers, Tilray is struggling after its fiscal 2019 third-quarter release. Though its revenue met estimates, its stock continues to slide.
- Advertisment -